Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 1, 2023
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes.
-
Aug 29, 2023
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare.
-
Aug 10, 2023
List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report from AARP’s Public Policy Institute shows.
-
Jun 30, 2023
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program.
-
Mar 31, 2023
AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today.
-
Feb 7, 2023
AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union speech this evening
-
Jan 25, 2023
AARP CEO Jo Ann Jenkins issued the following statement on the importance of protecting Social Security and Medicare
-
Dec 22, 2022
AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond issued the following statement on the Senate passage of the bipartisan 2023 omnibus bill. Earlier this month, AARP sent a letter to Congressional Leadership urging them to include important priorities for those age 50+ in any year-end legislative package.
-
Sep 27, 2022Lower Premiums and Deductibles Will Help Seniors with Rising Costs Due to Inflation
The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.
-
Aug 16, 2022New Law Will Lower Prescription Drug Prices for Seniors and Limit Medicare Plan Out-of-Pocket Costs
AARP issued a statement from Jo Ann Jenkins, AARP Chief Executive Officer, after President Biden signed the Inflation Reduction Act of 2022.